Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria

被引:10
|
作者
Gao, Long [1 ,2 ]
Li, Man-Biao [3 ]
Li, Jin-Yu [1 ,2 ]
Liu, Yang [3 ]
Ren, Chao [3 ]
Feng, Dui-Ping [1 ,2 ,4 ]
机构
[1] Shanxi Med Univ, Dept Oncol & Vasc Intervent, Hosp 1, Taiyuan 030001, Shanxi Province, Peoples R China
[2] Shanxi Med Univ, Shanxi Prov Clin Res Ctr Intervent Med, Hosp 1, Taiyuan 030001, Shanxi Province, Peoples R China
[3] Shanxi Med Univ, Coll Med Imaging, Taiyuan 030001, Shanxi Province, Peoples R China
[4] Shanxi Med Univ, Dept Oncol & Vasc Intervent, Hosp 1, 85 Jiefang South Rd, Taiyuan 030001, Shanxi Province, Peoples R China
关键词
Liver cirrhosis; Cirrhosis recompensation; Complications; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Predictors; TIPS; MANAGEMENT;
D O I
10.3748/wjg.v29.i38.5383
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDTransjugular intrahepatic portosystemic shunt (TIPS) is the standard second-line treatment option for individuals with complications of decompensated cirrhosis, such as variceal bleeding and refractory ascites.AIMTo investigate whether recompensation existed in TIPS-treated patients with decompensated cirrhosis according to Baveno VII criteria.METHODSThis retrospective analysis was performed on 64 patients who received TIPS for variceal bleeding or refractory ascites. The definition of recompensation referred to Baveno VII criteria and previous study. Clinical events, laboratory tests, and radiological examinations were regularly conducted during a preset follow-up period. The recompensation ratio in this cohort was calculated. Beyond that, univariate and multivariate regression models were conducted to identify the predictors of recompensation.RESULTSOf the 64 patients with a 12-mo follow-up, 20 (31%) achieved recompensation. Age [odds ratio (OR): 1.124; 95% confidence interval (CI): 1.034-1.222] and post-TIPS portal pressure gradient < 12 mmHg (OR: 0.119; 95%CI: 0.024-0.584) were identified as independent predictors of recompensation in patients with decompensated cirrhosis after TIPS.CONCLUSIONThe present study demonstrated that nearly one-third of the TIPS-treated patients achieved recompensation within this cohort. According to our findings, recompensation is more likely to be achieved in younger patients. In addition, postoperative portal pressure gradient reduction below 12 mmHg contributes to the occurrence of recompensation.
引用
收藏
页码:5383 / 5394
页数:12
相关论文
共 44 条
  • [31] Risk of HCC decreases in HBV-related patients with cirrhosis acquired recompensation: A retrospective study based on Baveno VII criteria
    Zhang, Yiheng
    Liu, Xu
    Li, Shu
    Lin, Chunlei
    Ye, Qian
    Wang, Yuying
    Wu, Juanli
    Zhang, Yushuang
    Gao, Han
    Li, Tao
    Qu, Yundong
    Wang, Yan
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (01)
  • [32] Prevention of infectious complications after transjugular intrahepatic portosystemic shunt (TIPS) in patients with cirrhosis of the liver with a single dose of ceftriaxon
    Gulberg, V
    Deibert, P
    Ochs, A
    Rossle, M
    Gerbes, AL
    HEPATOLOGY, 1997, 26 (04) : 1557 - 1557
  • [33] VALIDATION AND IMPACT OF RECOMPENSATION USING BAVENO VII CRITERIA AFTER SUSTAINED VIRAL RESPONSE AMONG PATIENTS WITH HEPATITIS C-RELATED DECOMPENSATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS
    Rosales Renteria, Luis Alejandro
    Lopez Rubio, Diana Laura
    Hirata Medina, Nancy Midory
    Jaramillo, Hiram
    Sandoval Briones, Jocelin
    Tinoco, Laramie
    Sandoval Gutierrez, Diana
    Prieto Nava, David
    Bravo Cabrera, Araceli
    Ruiz Lujan, Rodolfo
    Gonzalez Huezo, Maria Sarai
    Camacho Escobedo, Jesus Alberto
    HEPATOLOGY, 2023, 78 : S1422 - S1423
  • [34] NEUTROPHIL-TO-LYMPHOCYTE RATIO PREDICTS 30-DAY MORTALITY IN PATIENTS WITH DECOMPENSATED CIRRHOSIS UNDERGOING TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT
    Aiyan, Mahmoud
    Zhang, Wei
    Khan, Walid
    Thompson, Blake
    Morelli, Giuseppi
    HEPATOLOGY, 2020, 72 : 1076 - 1076
  • [35] Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study
    Huang, Maotao
    Feng, Zaoming
    Ji, Daijin
    Gao, Yaling
    Shi, Xiaoying
    Chen, Ping
    Wang, Ping
    Tang, Min
    Liu, Kai
    CYTOTHERAPY, 2014, 16 (11) : 1575 - 1583
  • [36] Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion
    Tan, Hiang Keat
    James, Paul Damien
    Sniderman, Kenneth Wilfred
    Wong, Florence
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (02) : 389 - 395
  • [37] Development and validation of a machine learning-based model to predict survival in patients with cirrhosis after transjugular intrahepatic portosystemic shunt
    Da, Binlin
    Chen, Huan
    Wu, Wei
    Guo, Wuhua
    Zhou, Anru
    Yin, Qin
    Gao, Jun
    Chen, Junhui
    Xiao, Jiangqiang
    Wang, Lei
    Zhang, Ming
    Zhuge, Yuzheng
    Zhang, Feng
    ECLINICALMEDICINE, 2025, 79
  • [38] Impact of pre-operative transjugular intrahepatic portosystemic shunt on post-operative outcomes following non-transplant surgeries in patients with decompensated cirrhosis
    Patel, Pragnesh
    Irani, Malcolm
    Graviss, Edward A.
    Nguyen, Duc T.
    Quigley, Eamonn M. M.
    Victor, David W., III
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 8
  • [39] Impact of pre-operative transjugular intrahepatic portosystemic shunt on post-operative outcomes following non-transplant surgeries in patients with decompensated cirrhosis
    Patel, Pragnesh
    Irani, Malcolm
    Graviss, Edward A.
    Nguyen, Duc T.
    Quigley, Eamonn M. M.
    Victor, David W., III
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 8
  • [40] The Freiburg index of post-transjugular intrahepatic portosystemic shunt survival (FIPS) score is a superior predictor of 1-year mortality in patients hospitalized with decompensated liver cirrhosis
    Kalo, E.
    Moore, O.
    George, J.
    Read, S.
    Ahlenstiel, G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 86 - 87